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Abstract
Objectives—To assess the impact of aggressive protocol to decrease door-to-balloon (DTB) 
time on the incidence of false-positive STEMI (FP-STEMI) and in-hospital mortality.
Patients—Consecutive patients with presumed STEMI with confirmed ST-segment elevation 
that underwent emergent catheterization.
Methods—In July 1, 2009 we instituted an aggressive protocol to further reduce DTB time. A 
quality improvement (QI) initiative was initiated in January 1, 2010 to maintain short DTB while 
improving outcomes. Outcomes were compared before and after aggressive DTB and similarly 
before and after the QI initiative. Outcomes were DTB time, the incidence of FP-STEMI and in-
hospital mortality. A review of the emergency catheterization database over the last 10 years 
(January 2001-December 2010) was carried out for historical comparison.
Results—Between July 1, 2008 and December 1, 2012, 1031 consecutive patients with presumed 
STEMI were assessed. Of these 170 were considered FP-STEMI. The median DTB time 
decreased from 76 to 61 minutes with the aggressive DTB protocol (P=. 001), accompanied by an 
increase of FP-STEMI (7.7% vs. 16.5%, p=.02). While TP-STEMI in-hospital mortality witnessed 
non-significant reduction, this was associated with a significant increase of FP-STEMI in-hospital 
mortality. After the QI initiative, a shorter DTB time (59 minutes) was maintained while 
decreasing FP-STEMI in-hospital mortality.
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Conclusion—Aggressive measures to reduce DTB time were associated with an increased 
incidence of FP-STEMI and FP-STEMI in-hospital mortality. Efforts to reduce DTB time should 
be monitored systematically to avoid unnecessary procedures that may delays other appropriate 
therapies in critically ill patients.
Keywords
Door to balloon Time; ST-segment myocardial infarction; False Positive STEMI; Quality 
Improvement
INTRODUCTION
Management of acute ST-segment elevation myocardial infarction (STEMI) has undergone 
significant changes in recent decades. The introduction of primary coronary intervention 
(PCI) as the primary method of reperfusion resulted in decreased morbidity and in-hospital 
mortality.1 The time from hospital arrival to onset of reperfusion therapy, [door-to-balloon 
(DTB) time), is an important determinant for outcomes. 2–8 The ACC/AHA guidelines were 
updated in 1999 to create a benchmark door-to-balloon time of less than 90 minutes for 
patients presenting with STEMI in a hospital capable of primary coronary intervention. 9 
There has been marked improvement in recent years. 10, 11 However, the new concept of 
first medical contact to balloon time and the pressure to reduce this time to less than 90 
minutes has led to additional effort to reduce the door to balloon even more, as shorter times 
may improve clinical outcomes, and they are being used as a measure of quality by many 
organizations. 12
Efforts to reduce the door-to-balloon time require a rapid triage decision with faster dispatch 
to the catheterization lab. However, this may come at the expense of increased risk of 
incorrect triage decisions and an increased rate of false-positive STEMI (FP-STEMI), 
whereby a patient is taken emergently to the catheterization laboratory but no STEMI is 
found. Many of these patients with FP-STEMI are critically ill and triaging them to 
unnecessary procedures in the cardiac catheterization may lead to suboptimal outcomes due 
to delay of disease-appropriate therapy. Although many studies have reported the benefits of 
shorter door to balloon time, few data exists on the incidence and outcomes of FP-
STEMI. 2–8, 13, 14 However, concerns about FP-STEMI and the effect on outcomes have 
been raised.15, 16 The aim of this study is to calculate the rate of true positive and false 
positive STEMI in 1031 patients consecutively enrolled in the current study between July 
2008 and December 2012 and to assess the association between an aggressive campaign to 
further reduce DTB times and median DTB time, the incidence of false-positive STEMI 
(FP-STEMI) and in-hospital mortality.
METHODS
Christiana Care Health System is a tertiary care center with nearly 1800 coronary 
interventions annually, including approximately 225 annual coronary interventions for 
STEMI. Emergency department physicians initiate the activation of the catheterization 
laboratory, but an interventional cardiologist must decide to proceed with emergent 
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angiography. With this strategy and a multidisciplinary effort we had achieved an excellent 
median DTB time under the national recommended guideline of 90 minutes.
In July of 2009, a more aggressive STEMI protocol was introduced at our institution with a 
goal of reducing DTB time to less than 60 minutes. The new protocol included more intense 
education efforts to instill the importance of shorter DTB time, and more aggressive quality 
assurance efforts, including positive feedback for shorter DTB time and negative feedback 
for delayed times.13 Emergency department physicians still activated the catheterization 
laboratory, but immediate contact with interventionalists via cellphone was provided. 
Performance improvement goals consisted of: a door to electrocardiogram time of less than 
5 minutes, immediate contact with interventionalist (<5 minutes), after hours arrival of staff 
to catheterization lab within 30 minutes and an overall DTB time of less than 60 minutes. 
Real-time feedback and notes of appreciation were given to all the staff involved in cases 
where the DTB time was less than 60 minutes. DTB time and FP-STEMI rates were 
measured.
Patient Selection
Consecutive patients presenting to our hospital with symptoms suggestive of STEMI, taken 
for emergency cardiac catheterization from July 1, 2008 to December, 1, 2010 were 
analyzed. Two attending cardiologists who were unaware of the patients’ clinical course 
independently evaluated electrocardiograms. We excluded patients who did not meet 
electrocardiographic criteria for ST elevation from further analysis (i.e. high risk non ST 
elevation MI), leaving a study population of patients who underwent emergent 
catheterization and had electrocardiographic criteria for ST elevation. Among this group, the 
interventionalist who performed the procedure made interventional decisions. True positive 
STEMI (TP-STEMI) was defined as those patients where a culprit lesion was identified 
regardless if they underwent coronary intervention (PCI), coronary artery bypass grafting 
(CABG) or medical therapy. A culprit lesion was defined as an occluded or significant 
(>70%) coronary stenosis in a location that could produce the ST elevation. FP-STEMI was 
defined as those in the study population where no culprit lesion or no significant coronary 
artery disease was found on coronary angiography and no rise in cardiac biomarkers with 
the temporal characteristics of acute coronary syndrome occurred. We compared the DTB 
time, the incidence of FP-STEMI, the incidence of in-hospital mortality in TP-STEMI and 
FP-STEMI within 12 months before and 12 months after the implementation of new strategy 
to reduce DTB time. Similarly, the DTB time, the incidence of FP-STEMI, the incidence of 
in-hospital mortality in TP-STEMI and FP-STEMI were compared with the transitional 
period of 6 months, during which the efforts to reduce DTB were implemented. In-hospital 
mortality was assessed at the time of hospital discharge. Debriefings were usually carried 
out after FP-STEMI to elucidate factors responsible for the clinical misdiagnosis. During the 
time of this study, previous EKGs were not always readily available or sought by the 
emergency department staff before catheterization lab activation. No thrombolytics or 
antithrombotics with the occasional exception of low-dose heparin boluses were given 
before the catheterization laboratory.
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A review of the emergency catheterization database over the last 10 years (January 2001-
December 2010) was carried out to assess historical rates of FP-STEMI.
Quality Improvement Initiative
After reviewing our internal data, we decided to implement a more robust internal quality 
improvement (QI) process in January 2011. We identified the risk of FP-STEMI and 
associated potential adverse outcomes. While we accepted the risk of having a higher 
incidence of FP-STEMI, we wanted to ensure no increase in in-hospital mortality incidence 
in this group. We did an extensive review of the database of all catheterization laboratory 
activations and emergency catheterizations for presumed STEMI for the preceding ten-year 
period. TP-STEMI as well as FP-STEMI were identified as explained above. We identified 
potential patients with FP-STEMI that carry the highest risk of in-hospital mortality when 
appropriate care is delayed due to cardiac catheterization (i.e. pulmonary embolism, CNS 
event requiring hypothermia, sepsis, misinterpretation of chronic EKG changes as the cause 
of an acute illness, etc.). We used the lessons from reviewing these cases to develop a 
teaching intervention for all caregivers involved to encourage a higher quality, albeit rapid, 
clinical evaluation to exclude these possibilities before sending a suspected STEMI to the 
catheterization laboratory. Presentations of these cases were provided to ED attending and 
residents as well as interventional cardiologists and fellows. A monthly QI meeting 
displayed these presentations with slides showing potential suggestion to avoid such 
outcomes. The main goal was to maintain the shorter DTB for STEMI while avoiding those 
with other life-threatening disorders from diverting to the catheterization laboratory 
depriving them from early diagnosis and needed treatment. Diagnostic algorhythms for 
pulmonary embolism and intra-cerebral catastrpophe were reviewed and emphasized. 
Systematic comparison of presenting EKGs with previous tracings was strongly 
recommended, The Intense QI Initiative utilizing lessons learned from the previous 10 years 
of data were held between January 2011 and December 2012. We defined the first 12 
months of this initiative as a transition time. The monthly QI afterward addressed new cases 
and new goals for quality improvement. DTB times, rates of FP-STEMI and in-hospital 
mortality before the transitional time were compared with those during the transitional time, 
and for 12 months after the QI initiative transition time (January 2011 to December 2011 
and January 2012 to December 2012 respectively).
Statistics
Summary statistics included median door-to-balloon time; FP-STEMI and in-hospital 
mortality rates and odds ratios of FP-STEMI were compared in the intervals before, during 
the transition and after the implementation of the aggressive DTB protocol and before, 
during the transition and after the implementation of the aggressive QI initiative. Continuous 
variables were summarized using median (range) and categorical variables were 
summarized using frequency (%). Odds ratios were calculated for TP-STEMI, FP-STEMI, 
in-hospital mortality in all STEMI, in-hospital mortality in TP-STEMI, and in-hospital 
mortality in FP-STEMI. The student’s t-test for continuous variables and 2 test for 
categorical variables were used to compare univariate changes in outcomes between 
different groups. Logistic regression was used for multivariable analysis to control for 
confounders permitting adjusted comparison of outcomes. Covariates used for adjustment 
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were time of presentation (i.e. day time vs. night time and week day vs. weekend/holiday), 
years of experience of interventional cardiologist and years of experience of ER physicians. 
All tests are two tailed with P<. 05 considered significant. We used SPSS for Windows 
version 14.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
A total of 1031 STEMI patients were included; of these there were 861 TP-STEMI and 170 
FP-STEMI.
The impact of aggressive shorter DTB time before QI Implementation
Data from 233 patients before the aggressive DTB protocol were compared to 123 patients 
during the transitional period and 224 patients afterward. Details about TP-STEMI and FP-
STEMI in this cohort are displayed in table 1.
After the implementation of the new protocol to reduce DTB time, median DTB time 
decreased from the previous level of 76 minutes to 61 minutes (Figure 1). The decrease in 
observed median DTB time was accompanied by an increase in the percentage of FP-
STEMI from 7.7% to 16.5% (Table-1). The aggressive DTB protocol was not associated 
with a significant change in in-hospital mortality in TP-STEMI. However in-hospital 
mortality in FP-STEMI increased from 5.6% to 21.6% from the time before the aggressive 
DTB protocol was initiated to after the aggressive DTB protocol was initiated (P=. 03). 
(Table-1).
Analysis of the 10 years data used for Quality Improvement Initiative
A review of the emergency catheterization database revealed that over the last 10 years 
(January 2001-December 2010), the in-hospital mortality of all patients with TP-STEMI 
undergoing emergent coronary intervention was 6.1 % (105 of 1721) while the in-hospital 
mortality of FP-STEMI was 12.2% (89 of 728).
Table-2 summarizes the Causes of ST Elevation in all FP-STEMI patients and deceased FP-
STEMI patients in the historic 10 years and the 2008–2010 cohorts. The discrepancy in 
distribution of ST elevation etiology between the whole FP-STEMI cohort and the deceased 
cohort identified a higher risk group of disorders where early recognition may be essential to 
avoid unnecessary procedures that would delay appropriate care and may be harmful. 
Furthermore, the disorders leading to ST elevation in the deceased FP-STEMI are 
disproportionately represented in the 2008–2010 cohort when compared to the historical 
controls, possibly because the abbreviated clinical evaluation occurring in order to minimize 
DTB led to missed clinical clues to some of the high risk disorders causing ST elevation 
other than STEMI.
Debriefing after FP-STEMI usually revealed that clinical evaluation was abridged in part by 
concerns about not delaying DTB time if the patient was to be sent to the catheterization 
laboratory. All caregivers involved, paramedics, emergency department nurses and 
physicians as well as the interventionalists, expressed the same concerns.
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The impact of aggressive shorter DTB time after QI Implementation
The QI process was carried out intensively from January 2011 to December 2011 and was 
continued afterward. Data from the transitional period (January 2011–December 2011) and 
after the intense QI initiative (January 2012–December 2012) including 234 and 217 STEMI 
patients respectively were compared to the aggressive protocol data prior to the QI initiative 
(Table-3). The results showed that the trend for shorter DTB was still successful (DTB was 
down to 59 min), The FP-STEMI rate remained high (there was still intense pressure to 
minimize DTB times). However the in-hospital mortality in FP-STEMI appeared to decline 
significantly (21.6% to 4.5%; P=. 03), while maintaining the low in-hospital mortality rate 
of 1% in TP-STEMI (Table 3). Figure 1 illustrates the DTB times and FP-STEMI rates in 
the three-comparator groups (baseline, after DTB time reduction protocol, and after QI 
project. Transition periods have been removed)
DISCUSSION
In this study, an intense effort to reduce DTB time led to an increase in unnecessary 
emergency cardiac catheterization and a trend towards an increase in in-hospital mortality in 
the FP-STEMI group. Debriefings after unnecessary catheterization showed that physicians, 
paramedics and nurses involved in the care of possible STEMI patients were aware of the 
need to avoid long door-to-balloon time and hurried clinical evaluations. A review of a ten-
year database of inhospital mortality after unnecessary catheterization for suspected STEMI 
similarly revealed that this is a high-risk group. Focused efforts to exclude life-threatening 
causes of ST elevation that are not STEMI before proceeding with emergent catheterization 
may offer the opportunity to avoid an unnecessary procedure and provide more pertinent 
appropriate therapy. Special emphasis on excluding life-threatening causes of ST elevation 
other than STEMI (pulmonary embolism, intracerebral catastrophe, pre-existing ST 
elevation with a superimposed severe illness that is not a STEMI) is likely particularly 
important, as these patients gain no benefit, and may possibly deteriorate from an 
unnecessary trip to the catheterization laboratory. We believe this is why our FP-STEMI 
mortality dropped without a substantial change in the FP-STEMI rates.
Achieving shorter DTB time is difficult, but it is achievable as a result of numerous, 
hospital-wide efforts to encourage speed of diagnosis and treatment. 11, 17, 18 The pressure to 
expedite care might lead to excessive or inappropriate cardiac catheterization in patients 
with suspected STEMI.15, 16, 19 Although cardiac catheterization is considered a relatively 
low risk procedure, catheterization of FP-STEMI patients, who often have serious disorders 
not related to STEMI, may carry increased risks. Although all of the FP-STEMI patients we 
report on before 2011 had independent confirmation of their ST-segment elevation, and 
were not ‘misread’ electrocardiograms, many serious medical conditions can present with 
ST-segment elevation in the absence of STEMI. 20, 21 These patients are then exposed to the 
small risk of the angiographic procedure as well as the more problematic risks of delayed 
diagnosis and specific treatment for their acute problems. In a number of our patients this 
delay was felt to play a role in their poor outcome. Once a FP-STEMI catheterization is 
concluded, an interventional cardiologist is not the optimal physician nor is the 
catheterization lab the optimal location for further evaluation and treatment of these patients. 
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Indeed, there may be uncertainty about which physicians should continue the emergency 
care, and in which hospital site, leading to treatment delays, which may have negative 
consequences. For instance, in patients with pulmonary embolism delays in treatment 
initiation are associated with in-hospital mortality increases.22 Similarly, in patients with 
suspected STEMI post cardiac arrest, in whom simultaneous hypothermia and rapid 
catheterization are difficult to achieve, each hour delay in effective hypothermia increases 
in-hospital mortality 20%.23 Treatment delay may also have increased in-hospital mortality 
for the other serious medical conditions seen in our FP-STEMI group.
Our statistical analysis suggested decreasing DTB time was associated with increased 
incidence of FP-STEMI and in-hospital mortality in this group. The increased risk of in-
hospital mortality of FP-STEMI can be attributed to the fact that at least a subset of this 
patient group is at high risk from their acute condition, and any delay in specific treatment of 
that condition can be substantially harmful and should be avoided. Although our data comes 
from only a single center, large databases like the National Cardiovascular Data Registry 
(NCDR) cannot address this issue, as they do not track FP-STEMI catheterizations. 25
Pressure to reduce DTB time can lead to suboptimal evaluation of the patient in the 
Emergency Department by cardiologists, paramedics, nurses and Emergency Department 
physicians, as all are very concerned about prolonging DTB time. In fact, vigorous efforts to 
decrease door-to-balloon times have been shown at times to increase FP-STEMI without 
having an effect on DTB time, a potentially serious unintended consequence. 26. Our 
hospital, like many, consistently celebrates short DTB times, and vigorously investigates 
excessive DTB times to improve. However, there is no acknowledgement of efforts when a 
FP-STEMI is avoided.
Evaluation of the patient with suspected STEMI is at times difficult and it is likely that some 
of our FP-STEMI patients would have undergone catheterization, even with a more 
thorough clinical evaluation. But heretofore missing from any risk/benefit analysis of 
striving for shorter DTB time has been acknowledgement of any significant downsides of 
catheterization and the possible resulting delay of more appropriate care. 11, 17, 18
There are also detrimental aspects of emergent cardiac catheterization for FP-STEMI not 
related to the patient. In addition to the taxing of limited medical resources, there is the 
significant disruption of catheterization laboratory workflow and the care of other patients 
awaiting catheterization procedures during the working day. During evenings and nights, 
emergency procedures are usually carried out by physicians and staff who will work the next 
day, potentially increasing fatigue-related errors.27
Finally the pervasive attention to shorter DTB times may be somewhat illogical for many 
hospitals that have achieved reasonable door-to-balloon times, as while the curve relating 
inhospital mortality benefits to DTB time is steeper >90 minutes (times relatively common 
when lowering DTB times became a priority) it is relatively “flat” at the 60–90 minute 
interval. 7, 8 Recent data even suggest that there is no benefit whatsoever in lowering DTB 
times further once it is less than 90 minutes.,28, 29 The limited benefit of in-hospital 
mortality associated with more aggressive protocols coupled with the increased cost and 
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potential harms of unnecessacry cardiac catherizations and delay in care raises concerns, 
especially in hospitals that already have reasonable DTB time. The overutilization of 
resources, the potential costs and staff fatigue is especially worrisome as some centers have 
reported FP-STEMI rates as high as 36%. 26
Limitations
This is a single center, retrospective study. Our numbers are relatively small, especially for 
inhospital mortality, so the findings must be approached with caution. We report on patients 
with suspected STEMI with subsequently validated ST-elevation. Other studies have used 
different definitions, often suspected STEMI by Emergency physician decision without 
cardiologist review. The latter system may give a higher ‘false positive’ rate, and have a 
somewhat different patient makeup.
CONCLUSIONS
Aggressive measures to reduce an already acceptable DTB time can increase the incidence 
of FP-STEMI. Efforts to reduce DTB time have to be monitored systematically to avoid 
unnecessary procedures and the associated delay in receiving appropriate care for life 
threatening non-cardiac conditions, as FP-STEMI may be associated with poor outcome. 
Some “balancing” by addressing both FP-STEMI and DTB times may be optimal.15
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The Impact Of Aggressive DTB Protocol On Median DTB Time, Incidence And FP-STEMI 
From The Three-Comparator Intervals (baseline, after DTB time reduction protocol, and 
after QI project. Transition periods have been removed).
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Table 1
Decreasing door-to-balloon time, false-positive ST elevation Myocardial infarction (STEMI) and in-hospital 
mortality rate before, during the transition period and after the aggressive DTB Protocol.
Before Aggressive 





After Aggressive DTB 
Protocol before QI 
Initiative January – 
December 2010
P Value
All STEMI 233 123 224 N/A
Median DTB (min) 76 (39–261) 67 (33–229) 61 (31–157) .001
TP-STEMI 215 (92.7%) 112 (91%) 187 (83.5%) .01*
Odds ratio of TP-STEMI 1.0 (Referent) .9 (.4–1.9) .4 (.2–.8)
FP-STEMI 18 (7.7%) 11 (9%) 37 (16.5%) .02*
Odds ratio of FP-STEMI rate 1.0 (Referent) 1.2 (.5–2.6) 1.8 (1.0–3.2)
In-hospital mortality in TP-STEMI 8/225 (3.6%) 7/112 (6.3%) 2/187 (1.1%) .6*
Odds ratio of in-hospital mortality in TP-
STEMI
1.0 (Referent) 1.8 (.6–5.1) .3 (.1–1.4)
In-hospital mortality in FP-STEMI 1 /18 (5.6%) 3/11 (27 %) 8 /37 (21.6%) .03*
Odds ratio of in-hospital mortality in FP-
STEMI
1.0 (Referent) 6.3 (.6–71.3) 4.7 (.5–4.8)
STEMI= ST Elevation Myocardial Infarction, FP= False Positive, TP= True Positive, DTB= Door to Balloon, min=minutes.
*
P-value for the score test for trend of odds.
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Table 2
Causes of ST Elevation and disorders leading to death in the historic 10 years and the 2008–2010 cohorts.
Causes of ST Elevation in the 
FP-STEMI historic 10 years 
cohort (N= 728)
Clinical Disorders in the 
deceased FP-STEMI in the 
historic 10 years cohort (N= 89)
Causes of ST Elevation in the 
FP-STEMI 2008–2010 cohort 
(N= 66)
Clinical Disorders in the 
deceased FP-STEMI in 2008–
2010 cohort (N= 12)
• LVH: 32% (232)
• Early repolarization: 
18% (131)









• ST elevations 







• Out of hospital 
arrest: 30% (27)
• Sepsis with LBBB: 
14% (12)
• Aortic dissection: 10 
% (9)
• Sepsis with 
takotstubo 
cardiomyopathy: 8 % 
(7)
• Massive Pulmonary 
embolism: 7 % (6)
• Intracerebral 
catastrophe: 6% (5)
• Undetermined: 25% 
(23)
• LVH: 26% (17)
• LBBB: 14% (9)
• Early repolarization: 
12% (8)





abnormalities: 9 % 
(6)
• ST elevations 















• Out of hospital 
cardiac arrest 17% 
(2)
• Aortic dissection 
8% (1)
• Undetermined 17% 
(2).
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